{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:16:40Z","timestamp":1773281800859,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T00:00:00Z","timestamp":1276128000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s11892-010-0127-1","type":"journal-article","created":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T01:10:51Z","timestamp":1276045851000},"page":"270-275","source":"Crossref","is-referenced-by-count":28,"title":["Plasma Kallikrein and Diabetic Macular Edema"],"prefix":"10.1007","volume":"10","author":[{"given":"Edward P.","family":"Feener","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,10]]},"reference":[{"key":"127_CR1","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/S0161-6420(84)34102-1","volume":"91","author":"R Klein","year":"1984","unstructured":"Klein R, Klein BE, Moss SE, et al.: The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology 1984, 91:1464\u20131474.","journal-title":"Ophthalmology"},{"key":"127_CR2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/archopht.122.4.552","volume":"122","author":"JH Kempen","year":"2004","unstructured":"Kempen JH, O\u2019Colmain BJ, Leske MC, et al.: The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 2004, 122:552\u2013563.","journal-title":"Arch Ophthalmol"},{"key":"127_CR3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0161-6420(95)31052-4","volume":"102","author":"R Klein","year":"1995","unstructured":"Klein R, Klein BE, Moss SE, et al.: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 1995, 102:7\u201316.","journal-title":"Ophthalmology"},{"key":"127_CR4","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0161-6420(98)91020-X","volume":"105","author":"R Klein","year":"1998","unstructured":"Klein R, Klein BE, Moss SE, et al.: The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998, 105:1801\u20131815.","journal-title":"Ophthalmology"},{"key":"127_CR5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/112067210201200606","volume":"12","author":"R Lattanzio","year":"2002","unstructured":"Lattanzio R, Brancato R, Pierro L, et al.: Macular thickness measured by optical coherence tomography (OCT) in diabetic patients. Eur J Ophthalmol 2002, 12:482\u2013487.","journal-title":"Eur J Ophthalmol"},{"key":"127_CR6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ophtha.2008.10.016","volume":"116","author":"R Klein","year":"2009","unstructured":"Klein R, Knudtson MD, Lee KE, et al.: The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology 2009, 116:497\u2013503.","journal-title":"Ophthalmology"},{"key":"127_CR7","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.2337\/db05-1635","volume":"55","author":"DA Antonetti","year":"2006","unstructured":"Antonetti DA, Barber AJ, Bronson SK, et al.: Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 2006, 55:2401\u20132411.","journal-title":"Diabetes"},{"key":"127_CR8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nm1534","volume":"13","author":"BB Gao","year":"2007","unstructured":"\u2022\u2022 Gao BB, Clermont A, Rook S, et al.: Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat Med 2007, 13:181\u2013188. This article provides the first evidence that activation of PK can increase RVP and edema.","journal-title":"Nat Med"},{"key":"127_CR9","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1021\/pr800112g","volume":"7","author":"BB Gao","year":"2008","unstructured":"Gao BB, Chen X, Timothy N, et al.: Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy. J Proteome Res 2008, 7:2516\u20132525.","journal-title":"J Proteome Res"},{"key":"127_CR10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ajo.2006.04.023","volume":"142","author":"BY Kim","year":"2006","unstructured":"Kim BY, Smith SD, Kaiser PK: Optical coherence tomographic patterns of diabetic macular edema. Am J Ophthalmol 2006, 142:405\u2013412.","journal-title":"Am J Ophthalmol"},{"key":"127_CR11","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1167\/iovs.07-1257","volume":"49","author":"MD Davis","year":"2008","unstructured":"Davis MD, Bressler SB, Aiello LP, et al.: Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. Invest Ophthalmol Vis Sci 2008, 49:1745\u20131752.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"127_CR12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1755-3768.1981.tb08735.x","volume":"59","author":"B Krogsaa","year":"1981","unstructured":"Krogsaa B, Lund-Andersen H, Mehlsen J, et al.: The blood-retinal barrier permeability in diabetic patients. Acta Ophthalmol (Copenh) 1981, 59:689\u2013694.","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"127_CR13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/bjo.73.4.255","volume":"73","author":"WE Plehwe","year":"1989","unstructured":"Plehwe WE, Sleightholm MA, Kohner EM: Does vitreous fluorophotometry reflect severity of early diabetic retinopathy? Br J Ophthalmol 1989, 73:255\u2013260.","journal-title":"Br J Ophthalmol"},{"key":"127_CR14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1023\/A:1002192829817","volume":"97","author":"MF Marmor","year":"1999","unstructured":"Marmor MF: Mechanisms of fluid accumulation in retinal edema. Doc Ophthalmol 1999, 97:239\u2013249.","journal-title":"Doc Ophthalmol"},{"key":"127_CR15","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.2337\/diacare.25.12.2328","volume":"25","author":"ST Knudsen","year":"2002","unstructured":"Knudsen ST, Bek T, Poulsen PL, et al.: Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathy. Diabetes Care 2002, 25:2328\u20132334.","journal-title":"Diabetes Care"},{"key":"127_CR16","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(97)09137-X","volume":"351","author":"J Nussberger","year":"1998","unstructured":"Nussberger J, Cugno M, Amstutz C, et al.: Plasma bradykinin in angio-oedema. Lancet 1998, 351:1693\u20131697.","journal-title":"Lancet"},{"key":"127_CR17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.anai.2010.01.007","volume":"104","author":"AP Kaplan","year":"2010","unstructured":"Kaplan AP, Joseph K: The bradykinin-forming cascade and its role in hereditary angioedema. Ann Allergy Asthma Immunol 2010, 104:193\u2013204.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"127_CR18","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jaci.2007.02.012","volume":"119","author":"K Bork","year":"2007","unstructured":"Bork K, Frank J, Grundt B, et al.: Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). J Allergy Clin Immunol 2007, 119:1497\u20131503.","journal-title":"J Allergy Clin Immunol"},{"key":"127_CR19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrd3125","volume":"9","author":"B Zuraw","year":"2010","unstructured":"\u2022 Zuraw B, Yasothan U, Kirkpatrick P: Ecallantide. Nat Rev Drug Discov 2010, 9:189\u2013190. This article describes ecallantide, a first in the class of PK inhibitors.","journal-title":"Nat Rev Drug Discov"},{"key":"127_CR20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0065-2776(04)86005-X","volume":"86","author":"K Joseph","year":"2005","unstructured":"Joseph K, Kaplan AP: Formation of bradykinin: a major contributor to the innate inflammatory response. Adv Immunol 2005, 86:159\u2013208.","journal-title":"Adv Immunol"},{"key":"127_CR21","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1172\/JCI41084","volume":"120","author":"B Liu","year":"2010","unstructured":"Liu B, Linley JE, Du X, et al.: The acute nociceptive signals induced by bradykinin in rat sensory neurons are mediated by inhibition of M-type K+ channels and activation of Ca2+-activated Cl- channels. J Clin Invest 2010, 120:1240\u20131252.","journal-title":"J Clin Invest"},{"key":"127_CR22","doi-asserted-by":"crossref","first-page":"32989","DOI":"10.1074\/jbc.R109.027946","volume":"284","author":"G Sotiropoulou","year":"2009","unstructured":"Sotiropoulou G, Pampalakis G, Diamandis EP: Functional roles of human kallikrein-related peptidases. J Biol Chem 2009, 284:32989\u201332994.","journal-title":"J Biol Chem"},{"key":"127_CR23","doi-asserted-by":"crossref","first-page":"7994","DOI":"10.1074\/jbc.M709837200","volume":"283","author":"X Zhang","year":"2008","unstructured":"Zhang X, Tan F, Zhang Y, et al.: Carboxypeptidase M and kinin B1 receptors interact to facilitate efficient b1 signaling from B2 agonists. J Biol Chem 2008, 283:7994\u20138004.","journal-title":"J Biol Chem"},{"key":"127_CR24","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.yexcr.2009.10.022","volume":"316","author":"L Gao","year":"2010","unstructured":"Gao L, Chao L, Chao J: A novel signaling pathway of tissue kallikrein in promoting keratinocyte migration: activation of proteinase-activated receptor 1 and epidermal growth factor receptor. Exp Cell Res 2010, 316:376\u2013389.","journal-title":"Exp Cell Res"},{"key":"127_CR25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/35060059","volume":"3","author":"S Selvarajan","year":"2001","unstructured":"Selvarajan S, Lund LR, Takeuchi T, et al.: A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation. Nat Cell Biol 2001, 3:267\u2013275.","journal-title":"Nat Cell Biol"},{"key":"127_CR26","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa0803200","volume":"358","author":"TK Kishimoto","year":"2008","unstructured":"Kishimoto TK, Viswanathan K, Ganguly T, et al.: Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med 2008, 358:2457\u20132467.","journal-title":"N Engl J Med"},{"key":"127_CR27","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1182\/blood-2003-07-2510","volume":"103","author":"Z Shariat-Madar","year":"2004","unstructured":"Shariat-Madar Z, Mahdi F, Schmaier AH: Recombinant prolylcarboxypeptidase activates plasma prekallikrein. Blood 2004, 103:4554\u20134561.","journal-title":"Blood"},{"key":"127_CR28","first-page":"3208","volume":"118","author":"C Maas","year":"2008","unstructured":"Maas C, Govers-Riemslag JW, Bouma B, et al.: Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. J Clin Invest 2008, 118:3208\u20133218.","journal-title":"J Clin Invest"},{"key":"127_CR29","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1073\/pnas.022626899","volume":"99","author":"K Joseph","year":"2002","unstructured":"Joseph K, Tholanikunnel BG, Kaplan AP: Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII. Proc Natl Acad Sci U S A 2002, 99:896\u2013900.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"127_CR30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.bjp.0705210","volume":"140","author":"M Abdouh","year":"2003","unstructured":"Abdouh M, Khanjari A, Abdelazziz N, et al.: Early upregulation of kinin B1 receptors in retinal microvessels of the streptozotocin-diabetic rat. Br J Pharmacol 2003, 140:33\u201340.","journal-title":"Br J Pharmacol"},{"key":"127_CR31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/HYPERTENSIONAHA.108.117663","volume":"53","author":"JA Phipps","year":"2009","unstructured":"\u2022\u2022 Phipps JA, Clermont AC, Sinha S, et al.: Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability. Hypertension 2009, 53:175\u2013181. This article demonstrates that a systemically delivered PK inhibitor can reduce RVP.","journal-title":"Hypertension"},{"key":"127_CR32","first-page":"2273","volume":"41","author":"H Yasuyoshi","year":"2000","unstructured":"Yasuyoshi H, Kashii S, Zhang S, et al.: Protective effect of bradykinin against glutamate neurotoxicity in cultured rat retinal neurons. Invest Ophthalmol Vis Sci 2000, 41:2273\u20132278.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"127_CR33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0162-3109(99)00057-0","volume":"45","author":"H Takeda","year":"1999","unstructured":"Takeda H, Kimura Y, Higashida H, et al.: Localization of B2 bradykinin receptor mRNA in the rat retina and sclerocornea. Immunopharmacology 1999, 45:51\u201355.","journal-title":"Immunopharmacology"},{"key":"127_CR34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/bjp.2008.48","volume":"154","author":"M Abdouh","year":"2008","unstructured":"Abdouh M, Talbot S, Couture R, et al.: Retinal plasma extravasation in streptozotocin-diabetic rats mediated by kinin B(1) and B(2) receptors. Br J Pharmacol 2008, 154:136\u2013143.","journal-title":"Br J Pharmacol"},{"key":"127_CR35","first-page":"658","volume":"38","author":"HC Hatcher","year":"1997","unstructured":"Hatcher HC, Ma JX, Chao J, et al.: Kallikrein-binding protein levels are reduced in the retinas of streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci 1997, 38:658\u2013664.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"127_CR36","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3109\/02713689608995143","volume":"15","author":"JX Ma","year":"1996","unstructured":"Ma JX, King LP, Yang Z, et al.: Kallistatin in human ocular tissues: reduced levels in vitreous fluids from patients with diabetic retinopathy. Curr Eye Res 1996, 15:1117\u20131123.","journal-title":"Curr Eye Res"},{"key":"127_CR37","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000078617","volume":"218","author":"A Pinna","year":"2004","unstructured":"Pinna A, Emanueli C, Dore S, et al.: Levels of human tissue kallikrein in the vitreous fluid of patients with severe proliferative diabetic retinopathy. Ophthalmologica 2004, 218:260\u2013263.","journal-title":"Ophthalmologica"},{"key":"127_CR38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/exer.1996.0087","volume":"63","author":"JX Ma","year":"1996","unstructured":"Ma JX, Song Q, Hatcher HC, et al.: Expression and cellular localization of the kallikrein-kinin system in human ocular tissues. Exp Eye Res 1996, 63:19\u201326.","journal-title":"Exp Eye Res"},{"key":"127_CR39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.exer.2009.02.016","volume":"89","author":"JG Webb","year":"2009","unstructured":"Webb JG, Yang X, Crosson CE: Expression of the kallikrein\/kinin system in human anterior segment. Exp Eye Res 2009, 89:126\u2013132.","journal-title":"Exp Eye Res"},{"key":"127_CR40","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00125-003-1085-9","volume":"46","author":"G Gao","year":"2003","unstructured":"Gao G, Shao C, Zhang SX, et al.: Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage. Diabetologia 2003, 46:689\u2013698.","journal-title":"Diabetologia"},{"key":"127_CR41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.regpep.2004.09.002","volume":"124","author":"SR Lawson","year":"2005","unstructured":"Lawson SR, Gabra BH, Guerin B, et al.: Enhanced dermal and retinal vascular permeability in streptozotocin-induced type 1 diabetes in Wistar rats: blockade with a selective bradykinin B1 receptor antagonist. Regul Pept 2005, 124:221\u2013224.","journal-title":"Regul Pept"},{"key":"127_CR42","first-page":"1891","volume":"43","author":"P Jeppesen","year":"2002","unstructured":"Jeppesen P, Aalkjaer C, Bek T: Bradykinin relaxation in small porcine retinal arterioles. Invest Ophthalmol Vis Sci 2002, 43:1891\u20131896.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"127_CR43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.vph.2009.05.006","volume":"51","author":"N Kojima","year":"2009","unstructured":"Kojima N, Saito M, Mori A, et al.: Role of cyclooxygenase in vasodilation of retinal blood vessels induced by bradykinin in Brown Norway rats. Vascul Pharmacol 2009, 51:119\u2013124.","journal-title":"Vascul Pharmacol"},{"key":"127_CR44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1189\/jlb.1205744","volume":"80","author":"P Ehrenfeld","year":"2006","unstructured":"Ehrenfeld P, Millan C, Matus CE, et al.: Activation of kinin B1 receptors induces chemotaxis of human neutrophils. J Leukoc Biol 2006, 80:117\u2013124.","journal-title":"J Leukoc Biol"},{"key":"127_CR45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00281-008-0111-x","volume":"30","author":"AP Adamis","year":"2008","unstructured":"Adamis AP, Berman AJ: Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol 2008, 30:65\u201384.","journal-title":"Semin Immunopathol"},{"key":"127_CR46","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/369744a0","volume":"369","author":"V Parpura","year":"1994","unstructured":"Parpura V, Basarsky TA, Liu F, et al.: Glutamate-mediated astrocyte-neuron signalling. Nature 1994, 369:744\u2013747.","journal-title":"Nature"},{"key":"127_CR47","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1089\/jop.2006.22.310","volume":"22","author":"JG Webb","year":"2006","unstructured":"Webb JG, Husain S, Yates PW, et al.: Kinin modulation of conventional outflow facility in the bovine eye. J Ocul Pharmacol Ther 2006, 22:310\u2013316.","journal-title":"J Ocul Pharmacol Ther"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-010-0127-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-010-0127-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-010-0127-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T19:56:23Z","timestamp":1559418983000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-010-0127-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,10]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["127"],"URL":"https:\/\/doi.org\/10.1007\/s11892-010-0127-1","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,10]]}}}